Clever Leaves’ Portugal Operation Granted License to Cultivate, Sell, and Export Medical Cannabis

 Clever Leaves (the “Company”), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, announced today it has been granted a license from INFARMED I.P., the Portuguese regulatory authority with oversight over the pharmaceutical industry in Portugal, including medical cannabis, to cultivate, import and export Good Agricultural and Collecting Practice (GACP) quality dried flower, produced from […]

Clever Leaves Appoints David Kastin as General Counsel and Corporate Secretary

NEW YORK, Aug. 19, 2020 (GLOBE NEWSWIRE) — Clever Leaves (the “Company”), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, announced today the appointment of David M. Kastin as General Counsel and Corporate Secretary. David will oversee all aspects of the Company’s global legal activities and policies while supporting the CEO and Board of Directors […]

Clever Leaves Enters Australian Market with Supply Agreement with Cannatrek

Clever Leaves (the “Company”), a leading multi-national operator (MNO) and licensed producer of pharmaceutical-grade medical cannabinoids, today announced it has entered the Australian market with the arrival of its first white-labeled, semi-finished product shipment to Cannatrek, an Australian seed-to-patient medicinal cannabis producer. The two-year supply agreement includes various CBD oral solution concentrations for distribution through physician […]

Schultze Special Purpose Acquisition Corp. Announces Filing of a Registration Statement on SEC Form S-4 in Connection with its Proposed Business Combination with Clever Leaves, a Large-Scale Pharmaceutical-Grade Multi-National Cannabis Operator

Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“SAMA”) announced today that Clever Leaves Holdings Inc. (“Holdco”) filed with the U.S. Securities and Exchange Commission (“SEC”) a registration statement on Form S-4 (the “Registration Statement”), which includes a preliminary proxy statement of SAMA, in connection with its proposed business combination with Clever Leaves […]

Schultze Special Purpose Acquisition Corp. Announces a Definitive Agreement to Combine with Clever Leaves, a Large-Scale Pharmaceutical-Grade Multi-National Cannabis Operator

The transaction has been unanimously approved by the Boards of Directors of both SAMA and Clever Leaves and is expected to close in the fourth quarter of 2020, subject to regulatory and shareholder approvals, as well as other customary closing conditions. Upon closing, the company will be known as Clever Leaves Holdings Inc. Clever Leaves’ […]